7-CHLORO-5-(2-CHLOROPHENYL)-1,5-DIHYDRO-4,1-BENZOTHIAZEPIN-2(3H)-ONE manufacturers
- CGP37157
-
- $45.00 / 5mg
-
2026-03-13
- CAS:75450-34-9
- Min. Order:
- Purity: 99.92%
- Supply Ability: 10g
|
| | 7-CHLORO-5-(2-CHLOROPHENYL)-1,5-DIHYDRO-4,1-BENZOTHIAZEPIN-2(3H)-ONE Basic information |
| Product Name: | 7-CHLORO-5-(2-CHLOROPHENYL)-1,5-DIHYDRO-4,1-BENZOTHIAZEPIN-2(3H)-ONE | | Synonyms: | 7-CHLORO-5-(2-CHLOROPHENYL)-1,5-DIHYDRO-4,1-BENZOTHIAZEPIN-2(3H)-ONE;CGP 37157;7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepine-2(3H)-one;4,1-Benzothiazepin-2(3H)-one, 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-;7-chloro-5-(2-chlorophenyl)benzo[e][1,4]thiazepin-2(1H,3H,5H)-one;CGP-37157 - CAS 75450-34-9 - Calbiochem;1-benzothiazepine-2(3H)-one;7-Chloro-5-(2-chlorophenyl)-1 | | CAS: | 75450-34-9 | | MF: | C15H11Cl2NOS | | MW: | 324.22 | | EINECS: | | | Product Categories: | Ion transporter and other ion channel;Signalling | | Mol File: | 75450-34-9.mol |  |
| | 7-CHLORO-5-(2-CHLOROPHENYL)-1,5-DIHYDRO-4,1-BENZOTHIAZEPIN-2(3H)-ONE Chemical Properties |
| Boiling point | 479.8±45.0 °C(Predicted) | | density | 1.384±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: ≥20mg/mL | | form | White solid | | pka | 12.20±0.40(Predicted) | | color | white | | Stability: | Stable for 2 years from date of purchase as supplied. Solution in DMSO may be stored at -20°C for up to 3 months. | | InChI | 1S/C15H11Cl2NOS/c16-9-5-6-13-11(7-9)15(20-8-14(19)18-13)10-3-1-2-4-12(10)17/h1-7,15H,8H2,(H,18,19) | | InChIKey | KQEPIRKXSUIUTH-UHFFFAOYSA-N | | SMILES | Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1 |
| Hazard Codes | Xn,N | | Risk Statements | 22-50 | | Safety Statements | 61 | | WGK Germany | 3 | | Storage Class | 11 - Combustible Solids |
| | 7-CHLORO-5-(2-CHLOROPHENYL)-1,5-DIHYDRO-4,1-BENZOTHIAZEPIN-2(3H)-ONE Usage And Synthesis |
| Description | CGP-37157 (75450-34-9) inhibitsthe mitochondrial Na+-Ca2+exchanger (NCX) in isolated heart mitochondria, IC50=0.36 μM.1Does not inhibit the plasmalemmal NCX.2 Also inhibits voltage-gated Ca2+channels in intact cells and therefore its use in cellular studies must employ adequate controls.3 Prevents sudden death in a Guinea pig model of heart failure.4Displays pronounced cytoprotective effects in chromaffin cells5and in neuronal injury models.6Blood-brain barrier permeant. | | Uses | 7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one is a specific inhibitor of the mitochondrial Na+/Ca2+ exchanger. | | Uses | CGP-37157 has been used as a mitochondrial sodium-calcium exchanger (mNCX) inhibitor to study the role of normal mitochondrial calcium dynamics in sustaining dendritic spinogenesis. | | Definition | ChEBI: 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2-one is a benzothiazepine. | | General Description | CGP-37157 is a benzothiazepine compound, which is derived from clonazepam. It functions as a sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) antagonist and ryanodine receptor channels (RyR) agonist. CGP-37157 regulates intracellular signaling of calcium in smooth, cardiac and skeletal muscle cells and non-muscle systems. | | Biological Activity | Selective antagonist of the mitochondrial Na + -Ca 2+ exchanger (IC 50 = 0.4 μ M). | | Biochem/physiol Actions | Specific inhibitor of mitochondrial Na+/Ca2+ exchange as well as sarcoplasmic reticulum calcium-stimulated ATPase and possibly other calcium channels. | | storage | Room temperature | | References | [1] D A COX. Selectivity of inhibition of Na(+)-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157.[J]. Journal of Cardiovascular Pharmacology, 1993, 21 4: 595-599. DOI:10.1097/00005344-199304000-00013
[2] IYUKI NAMEKATA Hikaru T Shogo Hamaguchi. Pharmacological discrimination of plasmalemmal and mitochondrial sodium-calcium exchanger in cardiomyocyte-derived H9c2 cells.[J]. Biological & pharmaceutical bulletin, 2015, 38 1: 147-150. DOI:10.1248/bpb.b14-00525
[3] KYLE T BARON Stanley A T. CGP37157 modulates mitochondrial Ca2+ homeostasis in cultured rat dorsal root ganglion neurons[J]. European journal of pharmacology, 1997, 340 2: Pages 295-300. DOI:10.1016/s0014-2999(97)01433-7
[4] TING LIU. Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure.[J]. Circulation research, 2014, 115 1: 44-54. DOI:10.1161/circresaha.115.303062
[5] SANTOS M NICOLAU. Mitochondrial Na+/Ca2+-exchanger blocker CGP37157 protects against chromaffin cell death elicited by veratridine.[J]. Journal of Pharmacology and Experimental Therapeutics, 2009, 330 3: 844-854. DOI:10.1124/jpet.109.154765
[6] A RUIZ C M E Alberdi. CGP37157, an inhibitor of the mitochondrial Na+/Ca2+ exchanger, protects neurons from excitotoxicity by blocking voltage-gated Ca2+ channels[J]. Cell Death & Disease, 2014, 5 4: e1156-e1156. DOI:10.1038/cddis.2014.134 |
| | 7-CHLORO-5-(2-CHLOROPHENYL)-1,5-DIHYDRO-4,1-BENZOTHIAZEPIN-2(3H)-ONE Preparation Products And Raw materials |
|